Anna Kirstine Jørgensen1, Alvaro Goyanes1,2,3,4, Abdul W. Basit1,2
1 Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK
2 FABRX Ltd., Henwood House, Henwood, Ashford TN24 8DH, UK
3 FABRX Artificial Intelligence, Carretera de Escairón 14, Currelos (O Saviñao), CP 27543, Spain
4 Departamento de Farmacología, Farmacia y Tecnología, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Space exploration
Space exploration has been a hot topic for many decades, with the first human moon landing by the Apollo 11 in 1969 marking a new era for the possibilities of space research. Since then, several manned and unmanned missions to space have aimed at widening our understanding of not only extraterrestrial existences and conditions but their implications for life on Earth as we know it and potential future life elsewhere in the Galaxy. Governmental space exploration agencies, such as the U.S. National Aeronautics and Space Administration (NASA) and the Russian State Corporation for Space Activities (Roscosmos), have historically been responsible for all space exploration and discoveries, although private companies and enterprises are revolutionizing the sector.